- Home
- PSO vs PCVX Comparison
PSO vs PCVX Comparison
Compare PSO & PCVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PSO
- PCVX
- Stock Information
- Founded
- PSO 1844
- PCVX 2013
- Country
- PSO United Kingdom
- PCVX United States
- Employees
- PSO N/A
- PCVX N/A
- Industry
- PSO Books
- PCVX Biotechnology: Pharmaceutical Preparations
- Sector
- PSO Consumer Discretionary
- PCVX Health Care
- Exchange
- PSO Nasdaq
- PCVX Nasdaq
- Market Cap
- PSO 9.0B
- PCVX 12.5B
- IPO Year
- PSO 2000
- PCVX 2020
- Fundamental
- Price
- PSO $13.65
- PCVX $113.55
- Analyst Decision
- PSO
- PCVX Strong Buy
- Analyst Count
- PSO 0
- PCVX 7
- Target Price
- PSO N/A
- PCVX $147.50
- AVG Volume (30 Days)
- PSO 251.0K
- PCVX 1.3M
- Earning Date
- PSO 01-01-0001
- PCVX 11-04-2024
- Dividend Yield
- PSO 2.12%
- PCVX N/A
- EPS Growth
- PSO 23.43
- PCVX N/A
- EPS
- PSO 0.63
- PCVX N/A
- Revenue
- PSO $4,485,194,688.00
- PCVX N/A
- Revenue This Year
- PSO N/A
- PCVX N/A
- Revenue Next Year
- PSO $4.08
- PCVX N/A
- P/E Ratio
- PSO $20.69
- PCVX N/A
- Revenue Growth
- PSO N/A
- PCVX N/A
- 52 Week Low
- PSO $10.31
- PCVX $44.20
- 52 Week High
- PSO $14.20
- PCVX $119.50
- Technical
- Relative Strength Index (RSI)
- PSO 51.69
- PCVX 79.60
- Support Level
- PSO $13.87
- PCVX $77.21
- Resistance Level
- PSO $14.20
- PCVX $119.50
- Average True Range (ATR)
- PSO 0.11
- PCVX 4.31
- MACD
- PSO -0.03
- PCVX 3.42
- Stochastic Oscillator
- PSO 16.03
- PCVX 85.93
About PSO Pearson Plc
U.K.-listed Pearson is the world's largest educational provider. The company has been disposing of noncore businesses such as the Financial Times, The Economist, and publishing house Penguin, and is now focused on being an educational resource and testing provider. While Pearson's primary activity centres on higher-level education, the firm also has significant operations in providing clinical assessments, professional certification and testing.
About PCVX Vaxcyte Inc.
Vaxcyte Inc is a vaccine company seeking to improve global health by developing novel vaccines to treat patients suffering from the most common and deadly diseases. Its product comprises. of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-24, VAX-A1, and VAX-PG.